Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: Implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity

Molecular Pharmaceutics

Volumn 10, Issue 9, 2013, Pages 3459-3474

  Jain, Amit K ^a   Thanki, Kaushik ^a   Jain, Sanyog ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Caco 2 cell uptake; co encapsulation; oxidative stress; PLGA nanoparticles; quercetin; Tamoxifen

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; GELATINASE A; GELATINASE B; NANOPARTICLE; POLYMER; QUERCETIN; TAMOXIFEN CITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; DRUG UPTAKE; FEMALE; LIVER TOXICITY; NANOENCAPSULATION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CACO-2 CELLS; FEMALE; HUMANS; LACTIC ACID; NANOPARTICLES; OXIDATIVE STRESS; POLYGLYCOLIC ACID; POLYMERS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 84883581837     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400311j     Document Type: Article

References (43)

1. Jordan, V. C. Tamoxifen: a most unlikely pioneering medicine Nat. Rev. Drug Discovery 2003, 2 (3) 205-213
2. 32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen Carcinogenesis 1995, 16 (7) 1651-1654
3. Lettéron, P.; Labbe, G.; Degott, C.; Berson, A.; Fromenty, B.; Delaforge, M.; Larrey, D.; Pessayre, D. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice: Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant Biochem. Pharmacol. 1990, 39 (12) 2027-2034
4. Clemons, M.; Danson, S.; Howell, A. Tamoxifen (Nolvadex): A review: Antitumour treatment Cancer Treat. Rev. 2002, 28 (4) 165-180
5. Brookes, P. S.; Digerness, S. B.; Parks, D. A.; Darley-Usmar, V. Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin Free Radical Biol. Med. 2002, 32 (11) 1220-1228
6. Larson, A. J.; Symons, J. D.; Jalili, T. Quercetin: A treatment for hypertension? A review of efficacy and mechanisms Pharmaceuticals 2010, 3 (1) 237-250
7. Ghosh, D.; Ghosh, S.; Sarkar, S.; Ghosh, A.; Das, N.; Saha, K. D.; Mandal, A. K. Quercetin in vesicular delivery systems: Evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model Chem. Biol. Interact. 2010, 186 (1) 61-71
8. Janbaz, K. H.; Saeed, S. A.; Gilani, A. H. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents Phytomedicine 2004, 11 (5) 424-430
9. Granado-Serrano, A. B.; Martin, M. A.; Bravo, L.; Goya, L.; Ramos, S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2) J. Nutr. 2006, 136 (11) 2715-2721
10. Caltagirone, S.; Ranelletti, F. O.; Rinelli, A.; Maggiano, N.; Colasante, A.; Musiani, P.; Aiello, F. B.; Piantelli, M. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer Am. J. Respir. Cell Mol. Biol. 1997, 17 (1) 51-59
11. Shin, S. C.; Choi, J. S.; Li, X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats Int. J. Pharm. 2006, 313 (1) 144-149
12. Ma, Z. S.; Huynh, T. H.; Ng, C. P.; Do, P. T.; Nguyen, T. H.; Huynh, H. Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation Int. J. Oncol. 2004, 24 (5) 1297-1304
13. Oh, S. J.; Kim, O.; Lee, J. S.; Kim, J.; Kim, M. R.; Choi, H. S.; Shim, J. H.; Kang, K. W.; Kim, Y. C. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells Food Chem. Toxicol. 2010, 48 (11) 3227-3234
14. Lama, G.; Angelucci, C.; Bruzzese, N.; Nori, S. L.; D'Atri, S.; Turriziani, M.; Bonmassar, E.; Sica, G. Sensitivity of human melanoma cells to oestrogens, tamoxifen and quercetin: is there any relationship with type I and II oestrogen binding site expression? Melanoma Res. 1998, 8 (4) 313-322
15. Sotoca, A. M.; Ratman, D.; Van der Saag, P.; StrÃm, A.; Gustafsson, J. A.; Vervoort, J.; Rietjens, I. M.; Murk, A. J. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio J. Steroid Biochem. Mol. Biol. 2008, 112 (4-5) 171-178
16. Spencer, J. P. E.; Chowrimootoo, G.; Choudhury, R.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C. The small intestine can both absorb and glucuronidate luminal flavonoids FEBS Lett. 1999, 458 (2) 224-230
17. Gao, Y.; Wang, Y.; Ma, Y.; Yu, A.; Cai, F.; Shao, W.; Zhai, G. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion Colloids Surf., B 2009, 71 (2) 306-314
18. Ratnam, D. V.; Ankola, D. D.; Bhardwaj, V.; Sahana, D. K.; Kumar, M. N. V. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective J. Controlled Release 2006, 113 (3) 189-207
19. Jain, A. K.; Das, M.; Swarnakar, N. K.; Jain, S. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics Crit. Rev. Ther. Drug Carrier Syst. 2011, 28 (1) 1-45
20. Thanki, K.; Gangwal, R. P.; Sangamwar, A. T.; Jain, S. Oral delivery of anticancer drugs: Challenges and Opportunities J. Controlled Release 2013, 170 (1) 15-40
21. Wang, H.; Jia, Y.; Hu, W.; Jiang, H.; Zhang, J.; Zhang, L. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin Pharm. Dev. Technol. 2013, 18 (3) 694-700
22. Misra, R.; Sahoo, S. K. Coformulation of doxorubicin and curcumin in poly (d, l -lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells Mol. Pharmaceutics 2011, 8 (3) 852-866
23. Wang, Z.; Chui, W. K.; Ho, P. C. Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy Pharm. Res. 2011, 28 (3) 585-596
24. Song, X. R.; Cai, Z.; Zheng, Y.; He, G.; Cui, F. Y.; Gong, D. Q.; Hou, S. X.; Xiong, S. J.; Lei, X. J.; Wei, Y. Q. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles Eur. J. Pharm. Sci. 2009, 37 (3) 300-305
25. Song, X.; Zhao, Y.; Hou, S.; Xu, F.; Zhao, R.; He, J.; Cai, Z.; Li, Y.; Chen, Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency Eur. J. Pharm. Biopharm. 2008, 69 (2) 445-453
26. Florence, A. T. The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual Pharm. Res. 1997, 14 (3) 259-266
27. Clark, M.; Jepson, M. A.; Hirst, B. H. Exploiting M cells for drug and vaccine delivery Adv. Drug Delivery Rev. 2001, 50 (1-2) 81-106
28. Hussain, N.; Jaitley, V.; Florence, A. T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics Adv. Drug Delivery Rev. 2001, 50 (1-2) 107-142
29. Jain, A. K.; Swarnakar, N. K.; Godugu, C.; Singh, R. P.; Jain, S. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen Biomaterials 2011, 32 (2) 503-515
30. Kalaria, D. R.; Sharma, G.; Beniwal, V.; Ravi Kumar, M. N. V. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats Pharm. Res. 2009, 26 (3) 492-501
31. Jain, S.; Jain, A. K.; Pohekar, M.; Thanki, K. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: Implications on drug induced cardiotoxicity and nephrotoxicity Free Radical Biol. Med. 2013, 65C, 117-130
32. Jain, A. K.; Swarnakar, N. K.; Das, M.; Godugu, C.; Singh, R. P.; Rao, P. R.; Jain, S. Augmented anticancer efficacy of doxorubicin loaded polymeric nanoparticles after oral administration in breast cancer induced animal model Mol. Pharmaceutics 2011, 8 (4) 1140-1151
33. Song, X.; Zhao, Y.; Wu, W.; Bi, Y.; Cai, Z.; Chen, Q.; Li, Y.; Hou, S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency Int. J. Pharm. 2008, 350 (1) 320-329
34. Croll, T. I.; O'Connor, A. J.; Stevens, G. W.; Cooper-White, J. J. Controllable surface modification of poly (lactic-co-glycolic acid)(PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects Biomacromolecules 2004, 5 (2) 463-473
35. Jain, S.; Chauhan, D. S.; Jain, A. K.; Swarnakar, N. K.; Harde, H.; Mahajan, R. R.; Kumar, D.; Valvi, P. K.; Das, M.; Datir, S. R.; Thanki, K. A universal step-wise freeze drying process for lyophilization of pharmaceutical products. Indian patent application 2559/DEL/2011, filed September 06, 2011.
36. Jain, S.; Mittal, A.; K Jain, A.; R Mahajan, R.; Singh, D. Cyclosporin A loaded PLGA nanoparticle: Preparation, optimization, in-vitro characterization and stability studies Curr. Nanosci. 2010, 6 (4) 422-431
37. Date, A. A.; Nagarsenker, M. S.; Patere, S.; Dhawan, V.; Gude, R. P.; Hassan, P. A.; Aswal, V.; Steiniger, F.; Thamm, J.; Fahr, A. Lecithin-based novel cationic nanocarriers (Leciplex) II: Improving therapeutic efficacy of quercetin on oral administration Mol. Pharmaceutics 2011, 8 (3) 716-726
38. Swarnakar, N. K.; Jain, A. K.; Singh, R. P.; Godugu, C.; Das, M.; Jain, S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles Biomaterials 2011, 32 (28) 6860-6874
39. Gupta, R.; Mishra, P.; Mittal, A. Enhancing nucleic acid detection sensitivity of Propidium Iodide by a three nanometer interaction inside cells and in solutions J. Nanosci. Nanotechnol. 2009, 9 (4) 2607-2615
40. Chung, S. Y.; Sung, M. K.; Kim, N. H.; Jang, J. O.; Go, E. J.; Lee, H. J. Inhibition of P-glycoprotein by natural products in human breast cancer cells Arch. Pharm. Res. 2005, 28 (7) 823-828
41. Nilsson, U. W.; Dabrosin, C. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo Cancer Res. 2006, 66 (9) 4789-4794
42. Tan, W.-f.; Lin, L.-p.; Li, M.-h.; Zhang, Y.-X.; Tong, Y.-g.; Xiao, D.; Ding, J. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential Eur. J. Pharmacol. 2003, 459 (2) 255-262
43. Albukhari, A. A.; Gashlan, H. M.; El-Beshbishy, H. A.; Nagy, A. A.; Abdel-Naim, A. B. Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats Food Chem. Toxicol. 2009, 47 (7) 1689-1695